PBHAX | PHYEX | PBHAX / PHYEX | |
Total Expense Ratio | 0.74 | 0.91 | 81% |
Annual Report Gross Expense Ratio | 0.74 | 0.94 | 79% |
Fund Existence | 36 years | 8 years | - |
Gain YTD | 5.931 | 5.833 | 102% |
Front Load | 3% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 20.6B | 20.6B | 100% |
Annual Yield % from dividends | 6.97 | 6.81 | 102% |
Returns for 1 year | 9.33 | 9.14 | 102% |
Returns for 3 years | 22.82 | 22.22 | 103% |
Returns for 5 years | 25.56 | 24.55 | 104% |
Returns for 10 years | 68.36 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBRN | 24.36 | 0.66 | +2.78% |
iShares Neuroscience and Healthcare ETF | |||
PYPY | 11.67 | 0.24 | +2.10% |
YieldMax PYPL Option Income Strategy ETF | |||
RTH | 247.67 | 1.78 | +0.72% |
VanEck Retail ETF | |||
DECM | 31.95 | 0.01 | +0.03% |
FT Vest U.S. Eq Max Buffr ETF - Dec | |||
FPX | 153.93 | -1.51 | -0.97% |
First Trust US Equity Opportunities ETF |